CS
BPMC
Candriam SCA’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-52,066
| Closed | -$5.61M | – | 689 |
|
|
2024
Q2 | $5.61M | Buy |
52,066
+12,001
| +30% | +$1.29M | 0.03% | 327 |
|
|
2024
Q1 | $3.8M | Sell |
40,065
-10,156
| -20% | -$963K | 0.02% | 396 |
|
|
2023
Q4 | $4.63M | Sell |
50,221
-85,001
| -63% | -$7.84M | 0.03% | 340 |
|
|
2023
Q3 | $6.79M | Sell |
135,222
-16,000
| -11% | -$804K | 0.05% | 272 |
|
|
2023
Q2 | $9.56M | Sell |
151,222
-302,790
| -67% | -$19.1M | 0.07% | 253 |
|
|
2023
Q1 | $18.8M | Buy |
454,012
+195,701
| +76% | +$8.1M | 0.13% | 172 |
|
|
2022
Q4 | $11.3M | Hold |
258,311
| – | – | 0.08% | 249 |
|
|
2022
Q3 | $17M | Buy |
258,311
+1,139
| +0.4% | +$75.1K | 0.12% | 185 |
|
|
2022
Q2 | $13M | Buy |
257,172
+67,731
| +36% | +$3.42M | 0.11% | 190 |
|
|
2022
Q1 | $12.1M | Sell |
189,441
-162,802
| -46% | -$10.4M | 0.08% | 232 |
|
|
2021
Q4 | $37.7M | Buy |
352,243
+39,293
| +13% | +$4.21M | 0.24% | 107 |
|
|
2021
Q3 | $32.2M | Hold |
312,950
| – | – | 0.22% | 111 |
|
|
2021
Q2 | $27.5M | Sell |
312,950
-38,931
| -11% | -$3.42M | 0.19% | 126 |
|
|
2021
Q1 | $37.9M | Sell |
351,881
-1
| -0% | -$108 | 0.32% | 78 |
|
|
2020
Q4 | $39.5M | Sell |
351,882
-182,133
| -34% | -$20.4M | 0.31% | 78 |
|
|
2020
Q3 | $49.5M | Sell |
534,015
-344,629
| -39% | -$31.9M | 0.47% | 41 |
|
|
2020
Q2 | $68.5M | Buy |
878,644
+767,413
| +690% | +$59.9M | 0.72% | 20 |
|
|
2020
Q1 | $8.71M | Buy |
111,231
+40
| +0% | +$3.13K | 0.1% | 239 |
|
|
2019
Q4 | $8.91M | Buy |
+111,191
| New | +$8.91M | 0.1% | 242 |
|
|
2018
Q4 | – | Sell |
-45,000
| Closed | -$3.51M | – | 815 |
|
|
2018
Q3 | $3.51M | Buy |
45,000
+1,000
| +2% | +$78.1K | 0.05% | 388 |
|
|
2018
Q2 | $2.79M | Hold |
44,000
| – | – | 0.04% | 411 |
|
|
2018
Q1 | $4.04M | Hold |
44,000
| – | – | 0.07% | 325 |
|
|
2017
Q4 | $3.32M | Buy |
+44,000
| New | +$3.32M | 0.06% | 350 |
|